Palermo University, Italy
Forethinkers are those who can “imagine” and “see” results before working on them. Should you loose this, then better abandon research. (F, Marotta)
MD, Specialized in Gastroenterology, Fellow in gastroenterology at Chicago Univ. Nationwide-selected Registrar in gastroenterology, Univ. of Cape-Town, S. Africa under the pioneer prof. IN Marks. Holds the only European Japanese-spoken PhD (Hirosaki University, Japan) with pioneer work in pancreatology. Embassy-selected Fellow of Japanese Ministry of Science at Natl Cancer Center, Tokyo. Member of the Chinese Soc. of pancreatology, Molecular biology stage in London, Seoul. Hon. Research Professor at Dept of Nutrition, Texas W Univ., USA and Adjunt prof. at Nutrition dept, Sichuan University, China. Visiting prof. at major Asian universities. Has directed a research center in Japan for 10y and cooperated for 12y with Nobel Prof. Montagnier and Redox auhotiry prof. Packer. Advisory member of the CLS, Nazarbayev Univ. and Ministry of Science of Kazakhstan. Editor-board member of >35 intl. medical journals. Has received >10 international prizes (Japan Soc Hepatology 2002-5, Kumamoto Sci. Award 2004, Genomic Pioneer-2009 and Thomas Edison Award 2014-shared). Has co-edited 2 successful books on aging-intervention and >15 book chapters on Gut stem cells,probiotics, functional foods,nanotechnology and approaches for longevity promotion. Founder of ReGenera R&D International for Aging Intervention (the only EU-registered antiaging-related association in Italy) working on models of preventive/regenerative medicine cooperating as Chairman of the Foundation linked to VCC Medical Preventive Medicine Promotion, Beijing, China. At S. Babila Clinic – Vitality-CMB® Unit in Milano, Italy he pioneered integrated IV therapy, personalised BHRT and patented nutraceuticals. He has published >230 papers and presented >450 communications. International speaker at major universities and hospitals (Harvard, McGill, Osaka, Hasselt, Shanghai, Kobe, Kyoto, Tokyo, Kanazawa, Hiroshima, S.Diego, S.Barbara, Astana, Korea, Cairo etc.). Nominator for GI-related area for the Royal Canadian Society.
Strategic Scientific Consultant for Japanese, USA, EU drug and food supplements companies,
National Institute of Immunology, India.
My research interest has been emergent to develop translational disease intervention strategies against important human chronic diseases by cultivating the balance between tolerance versus immunity, abrogating inflammation, mediated by the gut microbiome. The project is based on the disruption of synchrony between the gut microbiome and metabolic rhythms by pathogenic infection.
United Biomedical, Asia (UBIA), Taiwan
Chang Yi Wang, founder, Chairperson and CSO of United Biomedical Asia (UBI Asia), is dedicated to discovery, development, and commercialization of immunotherapeutic vaccines and monoclonal antibodies for infectious diseases, allergies, and neurodegenerative disorders. She is passionate about delivering science-driven innovation with platform capabilities. In 1973, she was the first Asian woman accepted into Rockefeller University’s Ph.D. program., where she received training from, and worked with four, Nobel Laureates. Upon graduation she was head of Molecular Immunology laboratory at Sloan Kettering Institute She leveraged her research and management experience to establish UBI, with a strategy of keeping proprietary manufacturing technologies in-house. With UBI’s establishment Dr. Wang used designer peptides, proteins and monoclonal antibodies as the tool, combining her expertise in the field of immunology, virology and vaccinology for biomedical application in diagnostics, vaccines, and immunotherapeutics. Dr. Wang hash >140 peer-reviewed publications in prestigious journals (e.g. NEJM, Lancet, Science, J Exp Med, JCI, PLoS Pathogens etc)
